The 22nd CPHI China 2024 and the 17th PMEC China 2024 concluded successfully at the Shanghai New International Expo Center on June 21st! The three-day exhibition brought together more than 3400 elites and leading enterprises in the pharmaceutical industry from home and abroad, providing a valuable platform for communication and cooperation within and outside the industry. As a leader in the field of pharmaceutical foreign trade, Dingkang Pharmaceutical is honored to participate in this grand event, not only showcasing the company's products and achievements, but also deeply participating in industry exchanges and cooperation.

Dingkang Pharmaceutical carefully selected a series of high-quality and competitive drugs for display at this conference, which received high attention from the attendees. Many exhibitors expressed strong interest in the efficacy, safety, and innovation of the company's products, further enhancing the brand influence of Dingkang Pharmaceutical in the international market.

During the exhibition, Dingkang Pharmaceutical had in-depth exchanges and cooperation with pharmaceutical companies, research and development institutions from all over the world. Through communication, we have learned about the latest developments and trends in the global pharmaceutical industry, providing useful references for the company's future development. With the continuous development of the global pharmaceutical industry, competition in the international market is becoming increasingly fierce. Dingkang Pharmaceutical will continue to increase its efforts in international market development and continuously enhance the company's international competitiveness.

Of course, this exhibition has also brought numerous business opportunities to Dingkang Pharmaceutical. We have reached preliminary cooperation intentions with multiple enterprises, laying the foundation for future cooperation. At the same time, we will continue to maintain close cooperation and communication with global pharmaceutical companies, research and development institutions, etc., to jointly promote innovation and development in the pharmaceutical industry. We also actively seek contacts with more potential partners to create more possibilities for the company's business expansion.

As a pharmaceutical foreign trader, we deeply understand that innovation is the key to leading the development of the industry. In the future, Dingkang Pharmaceutical will continue to increase its research and innovation cooperation, continuously improve the company's technological level and product quality, in order to meet the constantly changing needs of the global market.

The successful conclusion of the 22nd World Pharmaceutical Raw Materials China Exhibition has brought valuable opportunities and challenges to Dingkang Pharmaceutical. We will take this exhibition as an opportunity to continue to deepen our cultivation in the international market. At the same time, we also look forward to working together with colleagues in the global pharmaceutical industry to create a better future for the pharmaceutical industry.